Inhibitors of NLRP3 inflammasome
Abstract:
The present disclosure relates to compounds of Formula I:




that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with inflammation and inflammaging, including hearing loss and other diseases associated with aging.
Public/Granted literature
Information query
Patent Agency Ranking
0/0